Because of a small sample size and other factors, a large range of uncertainties flank the new findings. The vaccine’s strength against severe disease remains high.
Tag: Pfizer Inc
E.U. Drug Regulator Approves Moderna Vaccine for Ages 12 and Up
It is the second Covid vaccine to be approved for use for younger age groups in the 27-nation bloc.
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggests
Many who received the shot may need to consider boosters, the authors said. But federal health officials do not recommend second doses.
Israel Details Administering 3rd Shot for Immunocomprised People
The health ministry cited the rising infection rate as well as growing evidence that such people do not develop sufficient antibodies after two doses.
Thailand Will Give Health Workers a Mix of Chinese and Western Vaccines
The move comes after more than 600 medical employees who had received two doses of the Sinovac vaccine became infected.
Fauci Says Boosters Not Recommended ‘Right Now’
Dr. Anthony Fauci said federal agencies were conducting independent research on the potential need for vaccine boosters, and he reiterated school reopening guidance.
Citing the Delta Variant, Pfizer Will Pursue Booster Shots and a New Vaccine
Scientists were critical of the announcement, pointing to evidence that the current two-dose regimen is powerfully effective against the coronavirus.
Johnson & Johnson Vaccine Protects Against Delta Variant, Company Reports
The vaccine also produced long-lasting immune responses, researchers said. Booster shots seem unnecessary, at least for now.
Australian Officials Split Over AstraZeneca Vaccine Advice
With the Delta variant spreading, Prime Minister Scott Morrison is making the AstraZeneca vaccine available to younger people who want it. Some state officials say it’s the wrong call.
Three Studies, One Result: Coronavirus Vaccines Point the Way Out of the Pandemic
New scientific research underscores the effectiveness of vaccines and their versatility in the fight against the coronavirus.